sulfasalazine has been researched along with Short Bowel Syndrome in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taylor, SF | 1 |
| Sondheimer, JM | 1 |
| Sokol, RJ | 1 |
| Silverman, A | 1 |
| Wilson, HL | 1 |
1 other study available for sulfasalazine and Short Bowel Syndrome
| Article | Year |
|---|---|
Noninfectious colitis associated with short gut syndrome in infants.
Topics: Carbohydrate Metabolism; Colitis; Diarrhea, Infantile; Enteral Nutrition; Female; Gastrointestinal H | 1991 |